A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Mesa Laboratories Inc stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 2,993 shares of MLAB stock, worth $396,063. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,993
Previous 3,340 10.39%
Holding current value
$396,063
Previous $290,000 34.14%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$87.73 - $140.86 $30,442 - $48,878
-347 Reduced 10.39%
2,993 $389,000
Q2 2024

Jul 26, 2024

SELL
$84.94 - $122.22 $77,720 - $111,831
-915 Reduced 21.5%
3,340 $290,000
Q1 2024

Apr 24, 2024

SELL
$90.62 - $114.1 $60,081 - $75,648
-663 Reduced 13.48%
4,255 $467,000
Q4 2023

Feb 09, 2024

SELL
$84.55 - $115.06 $69,331 - $94,349
-820 Reduced 14.29%
4,918 $515,000
Q3 2023

Oct 24, 2023

SELL
$104.28 - $143.36 $2,294 - $3,153
-22 Reduced 0.38%
5,738 $603,000
Q2 2023

Jul 13, 2023

BUY
$125.33 - $184.35 $39,228 - $57,701
313 Added 5.75%
5,760 $740,000
Q1 2023

May 11, 2023

BUY
$163.15 - $203.76 $17,783 - $22,209
109 Added 2.04%
5,447 $952,000
Q4 2022

Feb 08, 2023

BUY
$118.55 - $188.84 $13,514 - $21,527
114 Added 2.18%
5,338 $887,000
Q3 2022

Oct 17, 2022

BUY
$139.58 - $214.98 $39,780 - $61,269
285 Added 5.77%
5,224 $735,000
Q2 2022

Jul 13, 2022

BUY
$182.13 - $260.0 $14,752 - $21,060
81 Added 1.67%
4,939 $1.01 Million
Q1 2022

May 12, 2022

SELL
$248.18 - $329.02 $6,700 - $8,883
-27 Reduced 0.55%
4,858 $1.24 Million
Q4 2021

Feb 03, 2022

BUY
$295.95 - $332.41 $223,442 - $250,969
755 Added 18.28%
4,885 $1.6 Million
Q3 2021

Nov 02, 2021

BUY
$266.92 - $322.44 $53,917 - $65,132
202 Added 5.14%
4,130 $1.25 Million
Q2 2021

Aug 10, 2021

BUY
$235.0 - $272.85 $30,550 - $35,470
130 Added 3.42%
3,928 $1.07 Million
Q1 2021

May 07, 2021

BUY
$243.02 - $297.01 $36,209 - $44,254
149 Added 4.08%
3,798 $924,000
Q4 2020

Feb 04, 2021

BUY
$258.4 - $289.99 $48,579 - $54,518
188 Added 5.43%
3,649 $1.05 Million
Q3 2020

Oct 29, 2020

BUY
$211.1 - $255.87 $50,875 - $61,664
241 Added 7.48%
3,461 $881,000
Q2 2020

Jul 27, 2020

BUY
$208.55 - $264.25 $84,254 - $106,757
404 Added 14.35%
3,220 $698,000
Q1 2020

May 08, 2020

BUY
$190.69 - $270.25 $114,795 - $162,690
602 Added 27.19%
2,816 $636,000
Q4 2019

Feb 04, 2020

BUY
$213.21 - $251.5 $5,330 - $6,287
25 Added 1.14%
2,214 $552,000
Q3 2019

Nov 06, 2019

BUY
$206.69 - $258.29 $14,261 - $17,822
69 Added 3.25%
2,189 $520,000
Q2 2019

Aug 15, 2019

BUY
$185.45 - $260.0 $17,246 - $24,180
93 Added 4.59%
2,120 $0
Q1 2019

May 08, 2019

BUY
$204.75 - $240.24 $32,145 - $37,717
157 Added 8.4%
2,027 $0
Q3 2018

Nov 02, 2018

SELL
$181.0 - $222.93 $349,692 - $430,700
-1,932 Reduced 50.82%
1,870 $0
Q2 2018

Aug 10, 2018

BUY
$142.4 - $211.08 $296,476 - $439,468
2,082 Added 121.05%
3,802 $0
Q1 2018

May 09, 2018

BUY
$124.77 - $152.86 $214,604 - $262,919
1,720 New
1,720 $0
Q4 2017

Feb 22, 2018

SELL
$124.3 - $160.83 $190,551 - $246,552
-1,533 Closed
0 $0
Q3 2017

Nov 07, 2017

BUY
$128.64 - $149.96 $8,747 - $10,197
68 Added 4.64%
1,533 $229,000
Q2 2017

Aug 08, 2017

BUY
N/A
1,465
1,465 $210,000

Others Institutions Holding MLAB

About MESA LABORATORIES INC


  • Ticker MLAB
  • Exchange NASDAQ
  • Sector Technology
  • Industry Scientific & Technical Instruments
  • Shares Outstandng 5,317,270
  • Market Cap $704M
  • Description
  • Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in the United States, Europe, the Asia Pacific, and internationally. The company's Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the ...
More about MLAB
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.